Characterisation of Cellular and Humoral Immune Responses Following the First Booster Immunisation With the Inactivated, Purified Japanese Encephalitis Vaccine IXIARO® in Elderly Compared to Young Individuals.
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2020
Price : $35 *
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- 17 Jan 2018 Location has been assumed as per the source considering the sponsor to be a medical university.
- 17 Jan 2018 New trial record